Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Antibody-Dependent Cellular Cytotoxic Response of PBMCs from Rituximab-Treated Individuals ADCC was reduced 1.7-fold (p = 0.0047) in rituximab-treated patients 4 months after

BMH history of treated, stable breast cancer brain metastases, CI confidence interval, GPA graded prognostic assessment, OS overall survival, PFS progression-free survival, SD

11 Figure S4 Kaplan-Meier estimates of progression-free survival (A) and overall survival (B) according to tumour sidedness in patients with BRAF- and/or PIK3CA mutations (n=44)...

While improvements were observed in all four patient groups and in practically all EQ-5D dimensions, after 3 months of follow-up varying proportions of patients still reported

Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure:

Pneumonia versus Graft Dysfunction as the cause of acute respiratory failure after Lung Transplant: A 4-year multicenter prospective study in 153 adults requiring.. intensive

Background: AURA study reported 61% objective response rate and progression-free survival of 9.6 months with osimertinib in patients with EGFR/T790M+ non-small cell lung cancer.. Due

The aim of the present study was to examine the association of craving and withdrawal with smoking cessation at the end of the treatment and relapse at 3 months follow-up in a